Cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric cancer: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

BACKGROUND: Cetuximab enhances the efficacy of chemotherapy in several cancer types. This trial assessed the activity of cetuximab and chemotherapy in advanced gastric cancer. METHODS: Patients with previously untreated, metastatic, gastric cancer received cetuximab 400 mg m(−2) at first infusion fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lordick, F, Luber, B, Lorenzen, S, Hegewisch-Becker, S, Folprecht, G, Wöll, E, Decker, T, Endlicher, E, Röthling, N, Schuster, T, Keller, G, Fend, F, Peschel, C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2822949/
https://www.ncbi.nlm.nih.gov/pubmed/20068568
http://dx.doi.org/10.1038/sj.bjc.6605521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2822949/
https://www.ncbi.nlm.nih.gov/pubmed/20068568
http://dx.doi.org/10.1038/sj.bjc.6605521

Ejemplares similares